Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Outcome

Krsnaa Diagnostics Board Meeting Outcome

Krsnaa Diagnostics announced its Board Meeting outcome involving the appointment of Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors. Additionally, Mr. Chandra Prakash Singh was named Interim CFO. Several directors completed their tenures, and the Board reconstituted various committees including Audit and Risk Management to strengthen corporate governance effective April 25, 2026.

Source

BSE filing, NSE: KRSNAA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Krsnaa Diagnostics Ltd: key numbers

Share price
₹503.75
Market cap
₹1,634 Cr
Revenue (annual)
₹772.8 Cr
Net profit (annual)
₹101.4 Cr
P/E (TTM)
16.8×Sector 52.8×
Promoter holding
27.11%+0.00% QoQ
FII holding
3.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Krsnaa Diagnostics Ltd

All →
07:34 IST BSE
Partnership

Krsnaa Diagnostics Partnership

Krsnaa Diagnostics has formed a strategic AI collaboration with AZmed to integrate AI radiology solutions for enhanced operational efficiency and scalable diagnostic reporting.

From
AZmed

Other board meeting outcome announcements

All →